New Alzheimer’s blood tests may be game-changers for treating the disease

By Robert Langreth | Bloomberg

There’s no simple way to tell who has Alzheimer’s disease, but with a blockbuster treatment for millions of Americans on the horizon, blood-test makers are gearing up to change this.

Even doctors who were initially skeptical about blood tests for the condition are gaining confidence that products from Quest Diagnostics Inc., Quanterix Corp. and C2N Diagnostics can help distinguish which patients may qualify for treatment with the experimental drug lecanemab, expected to be approved next year. The drug is the first ever to clearly slow the progress of Alzheimer’s, the brain-wasting disease that affects some 6 million Americans.

“These tests are getting better — not

→ Continue reading at Silicon Valley

More from author

Related posts

Advertisment

Latest posts

The Tantalizing Mystery of the Solar System’s Hidden Oceans

The original version of this story appeared in Quanta Magazine.For most of humankind’s existence, Earth was the only known ocean-draped world, seemingly unlike any...

The Role of Scholarships and Grants in Financing Education

Applying for scholarships and grants helps students pay for college. In some situations, these awards allow people to obtain a degree they wouldn't be...

EV, hybrid and gas-powered: Some interesting cars coming in 2024 | CNN Business

CNN  —  Next year will see the introduction of some new, genuinely affordable electric vehicles as well as...